Difference between revisions of "Team:ETH Zurich/References"

Line 6: Line 6:
 
<ul>
 
<ul>
 
<li id="IARC2014">International Agency for Research on Cancer. (2014). World cancer report 2014. <i>Geneva: WHO.</i></li>
 
<li id="IARC2014">International Agency for Research on Cancer. (2014). World cancer report 2014. <i>Geneva: WHO.</i></li>
 +
<li id="Sleijfer2007">Sleijfer, S., Gratama, J. W., Sieuwerts, A. M., Kraan, J., Martens, J. W., & Foekens, J. A. (2007). Circulating tumour cell detection on its way to routine diagnostic implementation?. <i>European Journal of Cancer</i>, 43(18), 2645-2650.</li>
 +
 +
 +
 +
 +
 +
<li id="Aguilera2008">Aguilera, L., Campos, E., Giménez, R., Badía, J., Aguilar, J., & Baldoma, L. (2008). Dual role of LldR in regulation of the lldPRD operon, involved in L-lactate metabolism in Escherichia coli. <i>Journal of bacteriology</i>, 190(8), 2997-3005.</li>
 +
<li id="Goentoro2009">Goentoro, L., Shoval, O., Kirschner, M. W., & Alon, U. (2009). The incoherent feedforward loop can provide fold-change detection in gene regulation. <i>Molecular cell</i>, 36(5), 894-899.</li>
 +
<li id="Srivastava2001">Srivastava, R. K. (2001). TRAIL/Apo-2L: mechanisms and clinical applications in cancer. <i>Neoplasia</i>, 3(6), 535-546.</li>
 +
<li id="Engeland1998">van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B., & Reutelingsperger, C. P. (1998). Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. <i>Cytometry</i>,31(1), 1-9.</li>
 +
<li id="Hawkins2002">Hawkins, T. E., Das, D., Young, B., & Moss, S. E. (2002). DT40 cells lacking the Ca<sup>2+</sup>-binding protein annexin 5 are resistant to Ca<sup>2+</sup>-dependent apoptosis. <i>Proceedings of the National Academy of Sciences</i>, 99(12), 8054-8059.</li>
 
</ul>
 
</ul>
  

Revision as of 17:49, 28 August 2015

"What I cannot create I do not understand."
- Richard Feynmann

References

Description

  • International Agency for Research on Cancer. (2014). World cancer report 2014. Geneva: WHO.
  • Sleijfer, S., Gratama, J. W., Sieuwerts, A. M., Kraan, J., Martens, J. W., & Foekens, J. A. (2007). Circulating tumour cell detection on its way to routine diagnostic implementation?. European Journal of Cancer, 43(18), 2645-2650.
  • Aguilera, L., Campos, E., Giménez, R., Badía, J., Aguilar, J., & Baldoma, L. (2008). Dual role of LldR in regulation of the lldPRD operon, involved in L-lactate metabolism in Escherichia coli. Journal of bacteriology, 190(8), 2997-3005.
  • Goentoro, L., Shoval, O., Kirschner, M. W., & Alon, U. (2009). The incoherent feedforward loop can provide fold-change detection in gene regulation. Molecular cell, 36(5), 894-899.
  • Srivastava, R. K. (2001). TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia, 3(6), 535-546.
  • van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B., & Reutelingsperger, C. P. (1998). Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry,31(1), 1-9.
  • Hawkins, T. E., Das, D., Young, B., & Moss, S. E. (2002). DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis. Proceedings of the National Academy of Sciences, 99(12), 8054-8059.
  1. International Agency for Research on Cancer. (2014). World cancer report 2014. Geneva: WHO.
  2. Sleijfer, S., Gratama, J. W., Sieuwerts, A. M., Kraan, J., Martens, J. W., & Foekens, J. A. (2007). Circulating tumour cell detection on its way to routine diagnostic implementation?. European Journal of Cancer, 43(18), 2645-2650.
  3. Cooke, T., Reeves, J., Lanigan, A., & Stanton, P. (2001). HER2 as a prognostic and predictive marker for breast cancer. Annals of oncology, 12(suppl 1), S23-S28.
  4. Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005). Molecular prognostic markers in pancreatic cancer: a systematic review. European Journal of Cancer, 41(15), 2213-2236.
  5. Singhal, S., Vachani, A., Antin-Ozerkis, D., Kaiser, L. R., & Albelda, S. M. (2005). Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non–small cell lung cancer: a review. Clinical Cancer Research,11(11), 3974-3986.
  6. Chen, Z., Lu, W., Garcia-Prieto, C., & Huang, P. (2007). The Warburg effect and its cancer therapeutic implications. Journal of bioenergetics and biomembranes, 39(3), 267-274.
  7. Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324(5930), 1029-1033.
  8. Aguilera, L., Campos, E., Giménez, R., Badía, J., Aguilar, J., & Baldoma, L. (2008). Dual role of LldR in regulation of the lldPRD operon, involved in L-lactate metabolism in Escherichia coli. Journal of bacteriology, 190(8), 2997-3005.
  9. Goentoro, L., Shoval, O., Kirschner, M. W., & Alon, U. (2009). The incoherent feedforward loop can provide fold-change detection in gene regulation. Molecular cell, 36(5), 894-899.
  10. Srivastava, R. K. (2001). TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia, 3(6), 535-546.
  11. van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B., & Reutelingsperger, C. P. (1998). Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry,31(1), 1-9.
  12. Hawkins, T. E., Das, D., Young, B., & Moss, S. E. (2002). DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis. Proceedings of the National Academy of Sciences, 99(12), 8054-8059.

Modeling

  • Marc Weber and Javier Buceta. Dynamics of the quorum sensing switch: stochastic and non-stationarye�ects.BMC Systems Biology, 7(1):6, January 2013.
  • Subhayu Basu, Yoram Gerchman, Cynthia H. Collins, Frances H. Arnold, and Ron Weiss. A synthetic multicellular system for programmed pattern formation. Nature, 434(7037):1130–1134, April 2005.
  • Lian-Hui Wang, Li-Xing Weng, Yi-Hu Dong, and Lian-Hui Zhang. Specificity and Enzyme Kinetics of the Quorum-quenching N-Acyl Homoserine Lactone Lactonase (AHL-lactonase). Journal of Biological Chemistry, 279(14):13645–13651, April 2004.